EMD-52478

Single-particle
3.06 Å
EMD-52478 Deposition: 07/01/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52478

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9hxi summary report (pdf.gz) Map-9hxi FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Bacterial antiviral defense protein Ec2ApeA from Escherichia coli strain 2-156-04_S4_C1 saturated with pdCpdG dinucleotide

EMD-52478

Single-particle
3.06 Å
EMD-52478 Deposition: 07/01/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Escherichia coli 2-156-04_S4_C1, synthetic construct
Sample: Bacterial antiviral defense protein Ec2ApeA from Escherichia coli strain 2-156-04_S4_C1 saturated with pdCpdG dinucleotide
Fitted models: 9hxi

Deposition Authors: Sasnauskas G, Juozapaitis J, Puteikiene R, Tamulaitiene G

ApeA is a deoxyribodinucleotide binding antiviral defense system targeting tRNA

Grant Support: